On March 27, 2019, SRNA Council passed the two policies that allow RN(NP)s, who regularly see people with Opioid Use Disorder (OUD) or who require methadone for pain, to apply to the SRNA to receive approval to prescribe medications such as suboxone and methadone. These regulatory processes are in follow up to the Bylaw passed by SRNA membership at the 2018 SRNA Annual Meeting. Based on this Bylaw, the SRNA has worked with provincial and national partners, including the Saskatchewan Health Authority, the Ministry of Health, the College of Physicians and Surgeons of Saskatchewan, Interdisciplinary Advisory Committees, and RN(NP) Advisory Committee, to develop the education and clinical practicum requirements, and regulatory processes.
The SRNA has developed regulatory processes to minimize harm to the public and develop expectations for safe prescribing. In accordance with the SRNA mandate to set standards for competence and govern prescribing, RN(NP)s must meet all requirements prior to receiving approval to prescribe drug therapeutics for OUD and methadone for pain. The RN(NP) prescribing of these additional medications will be monitored through the existing Prescription Review Program.
Advancing the RN(NP) Scope of Practice by enabling RN(NP)s to prescribe drug therapeutics for OUD will increase the number of approved prescribers in Saskatchewan; thereby providing increased access for clients.
Eligible RN(NP)s can begin the application process as of April 2, 2019.